UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
Unusual 11 Mid-Day Movers 10/21: (STX) (SYNA) (HAR) Higher; (CALX) (VRUS) (APKT) Lower
-
UBS Maintains a 'Buy' on Pharmasset (VRUS); Raising PT and Sales Estimates
-
Notable 52-Week Highs and Lows of the Day 09/06: (VRUS) (BTH) (AUY) High; (UBS) (ING) (MET) Low
-
Pre-Open Movers 09/06: (TIN) (VRUS) (BTH) Higher; (CS) (DNKN) (BAC) Lower (more...)
-
UPDATE - UBS Initiates Coverage on Pharmasset (VRUS) with a Buy; Going NUCLEAR
-
UBS Starts Pharmasset (VRUS) at Buy, $160 Price Target
-
Notable 52-Week Highs and Lows of the Day 06/08: (VRUS) (COG) (NLY) High; (TLB) (CSCO) (RIMM) Low
-
UBS Downgrades Pharmasset (VRUS) to Neutral
-
Pre-Open Movers 4/2: Best Buy (BBY) Higher on Results, Medarex (MEDX) Lower on Pfizer News
-
UBS Upgrades Pharmasset (VRUS) to Buy
-
UBS downgrades Pharmasset (VRUS) to Neutral
